The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Inherited Cancer Genome Testing Market Research Report 2025
Synopsis
The global Inherited Cancer Genome Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Inherited Cancer Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inherited Cancer Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Inherited Cancer Genome Testing in General Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Inherited Cancer Genome Testing include 23andMe, Agilent Technologies, Bio-Rad Laboratories, Centogene, Color Genomics, Gene By Gene, Illumina, LabCorp and Myriad Genetics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inherited Cancer Genome Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inherited Cancer Genome Testing.
Report Scope
The Inherited Cancer Genome Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inherited Cancer Genome Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inherited Cancer Genome Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific
Segment by Type
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others
Segment by Application
General Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inherited Cancer Genome Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Inherited Cancer Genome Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Inherited Cancer Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Inherited Cancer Genome Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Inherited Cancer Genome Testing in General Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Inherited Cancer Genome Testing include 23andMe, Agilent Technologies, Bio-Rad Laboratories, Centogene, Color Genomics, Gene By Gene, Illumina, LabCorp and Myriad Genetics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Inherited Cancer Genome Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inherited Cancer Genome Testing.
Report Scope
The Inherited Cancer Genome Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Inherited Cancer Genome Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Inherited Cancer Genome Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
23andMe
Agilent Technologies
Bio-Rad Laboratories
Centogene
Color Genomics
Gene By Gene
Illumina
LabCorp
Myriad Genetics
Positive Bioscience
Quest Diagnostics
Thermo Fisher Scientific
Segment by Type
Breast Cancer
Lung Cancer
Blood Cancer
Liver Cancer
Stomach Cancer
Others
Segment by Application
General Hospitals
Specialty Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Inherited Cancer Genome Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inherited Cancer Genome Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Breast Cancer
1.2.3 Lung Cancer
1.2.4 Blood Cancer
1.2.5 Liver Cancer
1.2.6 Stomach Cancer
1.2.7 Others
1.3 Market by Application
1.3.1 Global Inherited Cancer Genome Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 General Hospitals
1.3.3 Specialty Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Inherited Cancer Genome Testing Market Perspective (2019-2030)
2.2 Inherited Cancer Genome Testing Growth Trends by Region
2.2.1 Global Inherited Cancer Genome Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Inherited Cancer Genome Testing Historic Market Size by Region (2019-2024)
2.2.3 Inherited Cancer Genome Testing Forecasted Market Size by Region (2025-2030)
2.3 Inherited Cancer Genome Testing Market Dynamics
2.3.1 Inherited Cancer Genome Testing Industry Trends
2.3.2 Inherited Cancer Genome Testing Market Drivers
2.3.3 Inherited Cancer Genome Testing Market Challenges
2.3.4 Inherited Cancer Genome Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inherited Cancer Genome Testing Players by Revenue
3.1.1 Global Top Inherited Cancer Genome Testing Players by Revenue (2019-2024)
3.1.2 Global Inherited Cancer Genome Testing Revenue Market Share by Players (2019-2024)
3.2 Global Inherited Cancer Genome Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Inherited Cancer Genome Testing Revenue
3.4 Global Inherited Cancer Genome Testing Market Concentration Ratio
3.4.1 Global Inherited Cancer Genome Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inherited Cancer Genome Testing Revenue in 2023
3.5 Inherited Cancer Genome Testing Key Players Head office and Area Served
3.6 Key Players Inherited Cancer Genome Testing Product Solution and Service
3.7 Date of Enter into Inherited Cancer Genome Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inherited Cancer Genome Testing Breakdown Data by Type
4.1 Global Inherited Cancer Genome Testing Historic Market Size by Type (2019-2024)
4.2 Global Inherited Cancer Genome Testing Forecasted Market Size by Type (2025-2030)
5 Inherited Cancer Genome Testing Breakdown Data by Application
5.1 Global Inherited Cancer Genome Testing Historic Market Size by Application (2019-2024)
5.2 Global Inherited Cancer Genome Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Inherited Cancer Genome Testing Market Size (2019-2030)
6.2 North America Inherited Cancer Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Inherited Cancer Genome Testing Market Size by Country (2019-2024)
6.4 North America Inherited Cancer Genome Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Inherited Cancer Genome Testing Market Size (2019-2030)
7.2 Europe Inherited Cancer Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Inherited Cancer Genome Testing Market Size by Country (2019-2024)
7.4 Europe Inherited Cancer Genome Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Inherited Cancer Genome Testing Market Size (2019-2030)
8.2 Asia-Pacific Inherited Cancer Genome Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Inherited Cancer Genome Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Inherited Cancer Genome Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Inherited Cancer Genome Testing Market Size (2019-2030)
9.2 Latin America Inherited Cancer Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Inherited Cancer Genome Testing Market Size by Country (2019-2024)
9.4 Latin America Inherited Cancer Genome Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inherited Cancer Genome Testing Market Size (2019-2030)
10.2 Middle East & Africa Inherited Cancer Genome Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Inherited Cancer Genome Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Inherited Cancer Genome Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 23andMe
11.1.1 23andMe Company Detail
11.1.2 23andMe Business Overview
11.1.3 23andMe Inherited Cancer Genome Testing Introduction
11.1.4 23andMe Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.1.5 23andMe Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Detail
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Inherited Cancer Genome Testing Introduction
11.2.4 Agilent Technologies Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.2.5 Agilent Technologies Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Inherited Cancer Genome Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Centogene
11.4.1 Centogene Company Detail
11.4.2 Centogene Business Overview
11.4.3 Centogene Inherited Cancer Genome Testing Introduction
11.4.4 Centogene Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.4.5 Centogene Recent Development
11.5 Color Genomics
11.5.1 Color Genomics Company Detail
11.5.2 Color Genomics Business Overview
11.5.3 Color Genomics Inherited Cancer Genome Testing Introduction
11.5.4 Color Genomics Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.5.5 Color Genomics Recent Development
11.6 Gene By Gene
11.6.1 Gene By Gene Company Detail
11.6.2 Gene By Gene Business Overview
11.6.3 Gene By Gene Inherited Cancer Genome Testing Introduction
11.6.4 Gene By Gene Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.6.5 Gene By Gene Recent Development
11.7 Illumina
11.7.1 Illumina Company Detail
11.7.2 Illumina Business Overview
11.7.3 Illumina Inherited Cancer Genome Testing Introduction
11.7.4 Illumina Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.7.5 Illumina Recent Development
11.8 LabCorp
11.8.1 LabCorp Company Detail
11.8.2 LabCorp Business Overview
11.8.3 LabCorp Inherited Cancer Genome Testing Introduction
11.8.4 LabCorp Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.8.5 LabCorp Recent Development
11.9 Myriad Genetics
11.9.1 Myriad Genetics Company Detail
11.9.2 Myriad Genetics Business Overview
11.9.3 Myriad Genetics Inherited Cancer Genome Testing Introduction
11.9.4 Myriad Genetics Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.9.5 Myriad Genetics Recent Development
11.10 Positive Bioscience
11.10.1 Positive Bioscience Company Detail
11.10.2 Positive Bioscience Business Overview
11.10.3 Positive Bioscience Inherited Cancer Genome Testing Introduction
11.10.4 Positive Bioscience Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.10.5 Positive Bioscience Recent Development
11.11 Quest Diagnostics
11.11.1 Quest Diagnostics Company Detail
11.11.2 Quest Diagnostics Business Overview
11.11.3 Quest Diagnostics Inherited Cancer Genome Testing Introduction
11.11.4 Quest Diagnostics Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.11.5 Quest Diagnostics Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Inherited Cancer Genome Testing Introduction
11.12.4 Thermo Fisher Scientific Revenue in Inherited Cancer Genome Testing Business (2019-2024)
11.12.5 Thermo Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Inherited Cancer Genome Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Breast Cancer
Table 3. Key Players of Lung Cancer
Table 4. Key Players of Blood Cancer
Table 5. Key Players of Liver Cancer
Table 6. Key Players of Stomach Cancer
Table 7. Key Players of Others
Table 8. Global Inherited Cancer Genome Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Inherited Cancer Genome Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Inherited Cancer Genome Testing Market Size by Region (2019-2024) & (US$ Million)
Table 11. Global Inherited Cancer Genome Testing Market Share by Region (2019-2024)
Table 12. Global Inherited Cancer Genome Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 13. Global Inherited Cancer Genome Testing Market Share by Region (2025-2030)
Table 14. Inherited Cancer Genome Testing Market Trends
Table 15. Inherited Cancer Genome Testing Market Drivers
Table 16. Inherited Cancer Genome Testing Market Challenges
Table 17. Inherited Cancer Genome Testing Market Restraints
Table 18. Global Inherited Cancer Genome Testing Revenue by Players (2019-2024) & (US$ Million)
Table 19. Global Inherited Cancer Genome Testing Market Share by Players (2019-2024)
Table 20. Global Top Inherited Cancer Genome Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Cancer Genome Testing as of 2023)
Table 21. Ranking of Global Top Inherited Cancer Genome Testing Companies by Revenue (US$ Million) in 2023
Table 22. Global 5 Largest Players Market Share by Inherited Cancer Genome Testing Revenue (CR5 and HHI) & (2019-2024)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Inherited Cancer Genome Testing Product Solution and Service
Table 25. Date of Enter into Inherited Cancer Genome Testing Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Inherited Cancer Genome Testing Market Size by Type (2019-2024) & (US$ Million)
Table 28. Global Inherited Cancer Genome Testing Revenue Market Share by Type (2019-2024)
Table 29. Global Inherited Cancer Genome Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 30. Global Inherited Cancer Genome Testing Revenue Market Share by Type (2025-2030)
Table 31. Global Inherited Cancer Genome Testing Market Size by Application (2019-2024) & (US$ Million)
Table 32. Global Inherited Cancer Genome Testing Revenue Market Share by Application (2019-2024)
Table 33. Global Inherited Cancer Genome Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 34. Global Inherited Cancer Genome Testing Revenue Market Share by Application (2025-2030)
Table 35. North America Inherited Cancer Genome Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Inherited Cancer Genome Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Inherited Cancer Genome Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Inherited Cancer Genome Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Europe Inherited Cancer Genome Testing Market Size by Country (2019-2024) & (US$ Million)
Table 40. Europe Inherited Cancer Genome Testing Market Size by Country (2025-2030) & (US$ Million)
Table 41. Asia-Pacific Inherited Cancer Genome Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 42. Asia-Pacific Inherited Cancer Genome Testing Market Size by Region (2019-2024) & (US$ Million)
Table 43. Asia-Pacific Inherited Cancer Genome Testing Market Size by Region (2025-2030) & (US$ Million)
Table 44. Latin America Inherited Cancer Genome Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Latin America Inherited Cancer Genome Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Latin America Inherited Cancer Genome Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Middle East & Africa Inherited Cancer Genome Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 48. Middle East & Africa Inherited Cancer Genome Testing Market Size by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Inherited Cancer Genome Testing Market Size by Country (2025-2030) & (US$ Million)
Table 50. 23andMe Company Detail
Table 51. 23andMe Business Overview
Table 52. 23andMe Inherited Cancer Genome Testing Product
Table 53. 23andMe Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 54. 23andMe Recent Development
Table 55. Agilent Technologies Company Detail
Table 56. Agilent Technologies Business Overview
Table 57. Agilent Technologies Inherited Cancer Genome Testing Product
Table 58. Agilent Technologies Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 59. Agilent Technologies Recent Development
Table 60. Bio-Rad Laboratories Company Detail
Table 61. Bio-Rad Laboratories Business Overview
Table 62. Bio-Rad Laboratories Inherited Cancer Genome Testing Product
Table 63. Bio-Rad Laboratories Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 64. Bio-Rad Laboratories Recent Development
Table 65. Centogene Company Detail
Table 66. Centogene Business Overview
Table 67. Centogene Inherited Cancer Genome Testing Product
Table 68. Centogene Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 69. Centogene Recent Development
Table 70. Color Genomics Company Detail
Table 71. Color Genomics Business Overview
Table 72. Color Genomics Inherited Cancer Genome Testing Product
Table 73. Color Genomics Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 74. Color Genomics Recent Development
Table 75. Gene By Gene Company Detail
Table 76. Gene By Gene Business Overview
Table 77. Gene By Gene Inherited Cancer Genome Testing Product
Table 78. Gene By Gene Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 79. Gene By Gene Recent Development
Table 80. Illumina Company Detail
Table 81. Illumina Business Overview
Table 82. Illumina Inherited Cancer Genome Testing Product
Table 83. Illumina Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 84. Illumina Recent Development
Table 85. LabCorp Company Detail
Table 86. LabCorp Business Overview
Table 87. LabCorp Inherited Cancer Genome Testing Product
Table 88. LabCorp Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 89. LabCorp Recent Development
Table 90. Myriad Genetics Company Detail
Table 91. Myriad Genetics Business Overview
Table 92. Myriad Genetics Inherited Cancer Genome Testing Product
Table 93. Myriad Genetics Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 94. Myriad Genetics Recent Development
Table 95. Positive Bioscience Company Detail
Table 96. Positive Bioscience Business Overview
Table 97. Positive Bioscience Inherited Cancer Genome Testing Product
Table 98. Positive Bioscience Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 99. Positive Bioscience Recent Development
Table 100. Quest Diagnostics Company Detail
Table 101. Quest Diagnostics Business Overview
Table 102. Quest Diagnostics Inherited Cancer Genome Testing Product
Table 103. Quest Diagnostics Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 104. Quest Diagnostics Recent Development
Table 105. Thermo Fisher Scientific Company Detail
Table 106. Thermo Fisher Scientific Business Overview
Table 107. Thermo Fisher Scientific Inherited Cancer Genome Testing Product
Table 108. Thermo Fisher Scientific Revenue in Inherited Cancer Genome Testing Business (2019-2024) & (US$ Million)
Table 109. Thermo Fisher Scientific Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inherited Cancer Genome Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Inherited Cancer Genome Testing Market Share by Type: 2023 VS 2030
Figure 3. Breast Cancer Features
Figure 4. Lung Cancer Features
Figure 5. Blood Cancer Features
Figure 6. Liver Cancer Features
Figure 7. Stomach Cancer Features
Figure 8. Others Features
Figure 9. Global Inherited Cancer Genome Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 10. Global Inherited Cancer Genome Testing Market Share by Application: 2023 VS 2030
Figure 11. General Hospitals Case Studies
Figure 12. Specialty Clinics Case Studies
Figure 13. Inherited Cancer Genome Testing Report Years Considered
Figure 14. Global Inherited Cancer Genome Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Inherited Cancer Genome Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Inherited Cancer Genome Testing Market Share by Region: 2023 VS 2030
Figure 17. Global Inherited Cancer Genome Testing Market Share by Players in 2023
Figure 18. Global Top Inherited Cancer Genome Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inherited Cancer Genome Testing as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Inherited Cancer Genome Testing Revenue in 2023
Figure 20. North America Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Inherited Cancer Genome Testing Market Share by Country (2019-2030)
Figure 22. United States Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Inherited Cancer Genome Testing Market Share by Country (2019-2030)
Figure 26. Germany Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Inherited Cancer Genome Testing Market Share by Region (2019-2030)
Figure 34. China Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Inherited Cancer Genome Testing Market Share by Country (2019-2030)
Figure 42. Mexico Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Inherited Cancer Genome Testing Market Share by Country (2019-2030)
Figure 46. Turkey Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Inherited Cancer Genome Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. 23andMe Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 49. Agilent Technologies Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 50. Bio-Rad Laboratories Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 51. Centogene Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 52. Color Genomics Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 53. Gene By Gene Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 54. Illumina Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 55. LabCorp Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 56. Myriad Genetics Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 57. Positive Bioscience Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 58. Quest Diagnostics Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Inherited Cancer Genome Testing Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
